Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Isenberg

Showing results (181-190 of 280) with videos related to

Pageof 28
Sort By:
Thrombosis and Haemostasis|November 16, 2012
Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndromeCharis Pericleous, Lindsey A Clarke, Paul A Brogan, et al.
Arthritis and Rheumatism|April 29, 2006
Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosusSuzanne Donnelly, Wendy Roake, Simon Brown, et al.
Clinical and Experimental Immunology|December 10, 2024
Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patientsGuillem Montamat, Claire E Meehan, Hannah F Bradford, et al.
Rheumatology (Oxford, England)|October 13, 2022
Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular eventsNicola Farina, Ruya Abdulsalam, Thomas McDonnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr micePaul A Blair, Karina A Chavez-Rueda, Jamie G Evans, et al.
Arthritis and Rheumatism|February 5, 2010
Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosusSean G O'Neill, Ian Giles, Anastasia Lambrianides, et al.
Science Immunology|August 8, 2017
Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaqueEdward Smith, Sara Croca, Kirsty E Waddington, et al.
Rheumatology (Oxford, England)|February 29, 2020
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II studyEric F Morand, David A Isenberg, Daniel J Wallace, et al.
Annals of Internal Medicine|October 26, 2021
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled TrialMuhammad Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, et al.
Arthritis Research & Therapy|October 16, 2009
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal studyJessica J Manson, Alexander Ma, Pauline Rogers, et al.
Pageof 28

Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
Thrombosis and Haemostasis|November 16, 2012
Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndromeCharis Pericleous, Lindsey A Clarke, Paul A Brogan, et al.
Arthritis and Rheumatism|April 29, 2006
Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosusSuzanne Donnelly, Wendy Roake, Simon Brown, et al.
Clinical and Experimental Immunology|December 10, 2024
Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patientsGuillem Montamat, Claire E Meehan, Hannah F Bradford, et al.
Rheumatology (Oxford, England)|October 13, 2022
Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular eventsNicola Farina, Ruya Abdulsalam, Thomas McDonnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr micePaul A Blair, Karina A Chavez-Rueda, Jamie G Evans, et al.
Arthritis and Rheumatism|February 5, 2010
Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosusSean G O'Neill, Ian Giles, Anastasia Lambrianides, et al.
Science Immunology|August 8, 2017
Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaqueEdward Smith, Sara Croca, Kirsty E Waddington, et al.
Rheumatology (Oxford, England)|February 29, 2020
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II studyEric F Morand, David A Isenberg, Daniel J Wallace, et al.
Annals of Internal Medicine|October 26, 2021
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled TrialMuhammad Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, et al.
Arthritis Research & Therapy|October 16, 2009
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal studyJessica J Manson, Alexander Ma, Pauline Rogers, et al.
Pageof 28